Remove Communication Remove Pharmaceutical Remove Valuation
article thumbnail

Weekly Market Insight – October 31, 2022

Cornerstone Financial Advisory

AMGN), ConocoPhillips (COP), Regeneron Pharmaceuticals, Inc. Fixed income investments are subject to various risks including changes in interest rates, credit quality, inflation risk, market valuations, prepayments, corporate events, tax ramifications and other factors. (HUM), Cigna Corporation (CI), Booking Holdings, Inc.

Marketing 105
article thumbnail

Weekly Market Insight – August 1, 2022

Cornerstone Financial Advisory

BKNG), Occidental Petroleum Corporation (OXY), Regeneron Pharmaceuticals, Inc. Fixed income investments are subject to various risks including changes in interest rates, credit quality, inflation risk, market valuations, prepayments, corporate events, tax ramifications and other factors. Thursday: Block, Inc. (SQ), SQ), Twilio, Inc.

Marketing 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Weekly Market Insights: July 29th, 2024

Cornerstone Financial Advisory

BKNG), Vertex Pharmaceuticals Incorporated (VRTX), Regeneron Pharmaceuticals, Inc. Fixed income investments are subject to various risks including changes in interest rates, credit quality, inflation risk, market valuations, prepayments, corporate events, tax ramifications and other factors. (ADP) Thursday: Apple Inc.

article thumbnail

Small Caps: The Big Picture

Brown Advisory

As of the end of the first quarter of 2021, biotech comprised over half of the total health care weight in the index and, together with pharmaceuticals, it comprises nearly 66% of the sector. The strong price appreciation has resulted in a commensurate rise in valuations and a tsunami of new deal issuance in these areas.

article thumbnail

Small Caps: The Big Picture

Brown Advisory

As of the end of the first quarter of 2021, biotech comprised over half of the total health care weight in the index and, together with pharmaceuticals, it comprises nearly 66% of the sector. The strong price appreciation has resulted in a commensurate rise in valuations and a tsunami of new deal issuance in these areas.

article thumbnail

Weekly Market Insights – January 30, 2023

Cornerstone Financial Advisory

HON). Friday: Cigna Corporation(CI), Regeneron Pharmaceuticals, Inc. Fixed income investments are subject to various risks including changes in interest rates, credit quality, inflation risk, market valuations, prepayments, corporate events, tax ramifications and other factors. a Registered Investment Advisor.

article thumbnail

High FII Holding Stocks Under Rs 1000 Add To Your Watchlist 2024

Trade Brains

In FY23, their revenue from healthcare services was 96.03%, drugs and pharmaceutical supplies were 2.34%, and other operating revenue (ancillary activities, service exports, sponsorship, and educational income) was 1.63%. 440.65 ₹ 29,320 65.50% One97 Communications Ltd. Price to Book Value 8.44 FII Holdings (%) Delhivery Ltd.